The containment performance of ChargePoint PharmaSafe® split butterfly valves has been independently validated by customers and third-parties according to the ISPE SMEPAC (Standardised Measurement of Equipment Particulate Airborne Contamination) guidelines.
The validated performance value levels of the containment provided by the ChargePoint PharmaSafe® valve range is up to OEB5/<0.1ug/m3.
ChargePoint’s containment solutions provide a reduced risk of cross contamination via closed transfers, ensure the safety of your personnel and provide a dust free environment when processing toxic powders and high potent APIs for the pharmaceutical industry.
Our ChargePoint PharmaSafe® containment solutions can also maximise the yield of poorly flowing, high value products whilst removing the requirement for high air class control areas and cumbersome PPE.
The solutions offered by ChargePoint for contained transfers include:
Our containment solutions are available in a range of sizes to suit bulk powder handling requirements as well as small batch transfers of APIs and intermediates.
You can be sure that your process is in safe hands with ChargePoint’s containment technologies as they are designed to GMP standards, manufactured using FDA compliant materials and manufactured in facilities that conform to ATEX (European Hazardous Area Directive) HazLoc (North America Hazardous Area Directive) and PED (European Pressure Equipment Directive).
